Koers Stemsation International, Inc. Other OTC
Aandelen
STSN
US85859E1029
Overige speciaalzaken
Omzet 2017 | - | Omzet 2018 | - | Marktkapitalisatie | 1,36 mln. 1,26 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | - 0 | Nettowinst (verlies) 2018 | - 0 | EV/omzet 2017 | - |
Nettoschuld 2017 | 339K 313K | Nettoschuld 2018 | 340K 313K | EV/omzet 2018 | - |
K/w-verhouding 2017 |
-57,9
x | K/w-verhouding 2018 |
-46,1
x | Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 99% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Benjamin Silbert
CEO | Chief Executive Officer | 54 | 01-07-22 |
Nick Panza
COO | Chief Operating Officer | 38 | 06-08-19 |
David Casanova
SAM | Sales & Marketing | 60 | 01-08-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Benjamin Silbert
CEO | Chief Executive Officer | 54 | 01-07-22 |
Nick Panza
COO | Chief Operating Officer | 38 | 06-08-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-.--% | 843 mln. | |
-.--% | 671 mln. | |
+34,88% | 492 mln. | |
+19,13% | 231 mln. | |
-.--% | 151 mln. | |
+113,04% | 59,29 mln. |